Log In
Print
BCIQ
Print
Print this Print this
 

Rhopressa (AR-13324)

  Manage Alerts
Collapse Summary General Information
Company Aerie Pharmaceuticals Inc.
DescriptionDual inhibitor of Rho kinase and the norepinephrine transporter
Molecular Target Rho kinase ; Norepinephrine transporter
Mechanism of ActionRho kinase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationGlaucoma
Indication DetailsTreat glaucoma; Treat intraocular pressure (IOP) in glaucoma and ocular hypertension patients
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today